Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Alliance Hill Day Read More Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Prepping for the New Congress: Macro- and Micro-Budget Considerations for FDA and more Read More Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Congressional Calendar Leaves Little Time for Legislating Read More Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Senate and House in Recess Next Week Read More Advocacy at a Glance STEVEN GROSSMAN 12/18/15 Advocacy at a Glance STEVEN GROSSMAN 12/18/15 FY 16 Appropriations Nears Finale and more Read More Analysis and Commentary STEVEN GROSSMAN 12/11/15 Analysis and Commentary STEVEN GROSSMAN 12/11/15 And Still We Hold Our Breath in Hope Read More Advocacy at a Glance STEVEN GROSSMAN 12/11/15 Advocacy at a Glance STEVEN GROSSMAN 12/11/15 Senate HELP Committee Vote on FDA Commissioner Nomination Possible in January and more Read More Analysis and Commentary STEVEN GROSSMAN 12/4/15 Analysis and Commentary STEVEN GROSSMAN 12/4/15 When Can You "Show Me the Money"? Read More Advocacy at a Glance STEVEN GROSSMAN 12/4/15 Advocacy at a Glance STEVEN GROSSMAN 12/4/15 Appropriations Riders May Target Food Labeling and more Read More Advocacy at a Glance STEVEN GROSSMAN 11/20/15 Advocacy at a Glance STEVEN GROSSMAN 11/20/15 Califf Hearing Appears to Have Gone Well and more Read More Analysis and Commentary STEVEN GROSSMAN 11/16/15 Analysis and Commentary STEVEN GROSSMAN 11/16/15 Please Write to Appropriators NOW ... The Clock's Still Ticking Read More Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Not Too Late to Write Appropriators to Increase FY 16 Funding for the FDA and more Read More Analysis and Commentary STEVEN GROSSMAN 11/6/15 Analysis and Commentary STEVEN GROSSMAN 11/6/15 The Clock Is Ticking; Act Now Please! Read More Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Please Send Us Your Letter in Support of FDA Funding and more Read More Analysis and Commentary STEVEN GROSSMAN 10/30/15 Analysis and Commentary STEVEN GROSSMAN 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More Advocacy at a Glance STEVEN GROSSMAN 10/30/15 Advocacy at a Glance STEVEN GROSSMAN 10/30/15 How Does the Budget Deal Impact FDA’s Appropriations and more Read More Analysis and Commentary STEVEN GROSSMAN 10/23/15 Analysis and Commentary STEVEN GROSSMAN 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More Advocacy at a Glance STEVEN GROSSMAN 10/16/15 Advocacy at a Glance STEVEN GROSSMAN 10/16/15 Combination Products: an Expanding Area of FDA Responsibility and more Read More Analysis and Commentary STEVEN GROSSMAN 10/2/15 Analysis and Commentary STEVEN GROSSMAN 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More Older Posts
Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Advocacy at a Glance STEVEN GROSSMAN 4/21/17 Alliance Hill Day Read More
Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More
Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Prepping for the New Congress: Macro- and Micro-Budget Considerations for FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Advocacy at a Glance STEVEN GROSSMAN 6/25/16 Congressional Calendar Leaves Little Time for Legislating Read More
Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Advocacy at a Glance STEVEN GROSSMAN 4/30/16 Senate and House in Recess Next Week Read More
Advocacy at a Glance STEVEN GROSSMAN 12/18/15 Advocacy at a Glance STEVEN GROSSMAN 12/18/15 FY 16 Appropriations Nears Finale and more Read More
Analysis and Commentary STEVEN GROSSMAN 12/11/15 Analysis and Commentary STEVEN GROSSMAN 12/11/15 And Still We Hold Our Breath in Hope Read More
Advocacy at a Glance STEVEN GROSSMAN 12/11/15 Advocacy at a Glance STEVEN GROSSMAN 12/11/15 Senate HELP Committee Vote on FDA Commissioner Nomination Possible in January and more Read More
Analysis and Commentary STEVEN GROSSMAN 12/4/15 Analysis and Commentary STEVEN GROSSMAN 12/4/15 When Can You "Show Me the Money"? Read More
Advocacy at a Glance STEVEN GROSSMAN 12/4/15 Advocacy at a Glance STEVEN GROSSMAN 12/4/15 Appropriations Riders May Target Food Labeling and more Read More
Advocacy at a Glance STEVEN GROSSMAN 11/20/15 Advocacy at a Glance STEVEN GROSSMAN 11/20/15 Califf Hearing Appears to Have Gone Well and more Read More
Analysis and Commentary STEVEN GROSSMAN 11/16/15 Analysis and Commentary STEVEN GROSSMAN 11/16/15 Please Write to Appropriators NOW ... The Clock's Still Ticking Read More
Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Advocacy at a Glance STEVEN GROSSMAN 11/16/15 Not Too Late to Write Appropriators to Increase FY 16 Funding for the FDA and more Read More
Analysis and Commentary STEVEN GROSSMAN 11/6/15 Analysis and Commentary STEVEN GROSSMAN 11/6/15 The Clock Is Ticking; Act Now Please! Read More
Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Advocacy at a Glance STEVEN GROSSMAN 11/6/15 Please Send Us Your Letter in Support of FDA Funding and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/30/15 Analysis and Commentary STEVEN GROSSMAN 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More
Advocacy at a Glance STEVEN GROSSMAN 10/30/15 Advocacy at a Glance STEVEN GROSSMAN 10/30/15 How Does the Budget Deal Impact FDA’s Appropriations and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/23/15 Analysis and Commentary STEVEN GROSSMAN 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More
Advocacy at a Glance STEVEN GROSSMAN 10/16/15 Advocacy at a Glance STEVEN GROSSMAN 10/16/15 Combination Products: an Expanding Area of FDA Responsibility and more Read More
Analysis and Commentary STEVEN GROSSMAN 10/2/15 Analysis and Commentary STEVEN GROSSMAN 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More
